Impact Publications : AirCargo-261
AirCArgo AsiA-PACifiC • SEPT, 2019 • Page 5 DHl to focus on Australia’s healthcare niche as it challenges the ‘volatility’ in global trade AUSTRALIA’s thriving life sciences and healthcare industry is to be a key growth sector for DHL Global Forwarding. At the inaugural DHL Life Sciences and Healthcare Con- ference in Sydney, company representatives and customers discussed the future of the sector and how digitisation and technol- og y such as big data analytics and Internet of Things (IoT) are trans- forming supply chains to improve visibility, traceability and cost efficiency, with global healthcare expenditures forecast to reach A$14.84 trillion (US$10.06 trillion) by 2020. “Longer life expectancies, the prevalence of chronic diseases and a growing middle class have increased global demand for healthcare products and ser- vices. Key sector trends such as precision medication and tighter regulations compound the need for a competent and compliant logistics infrastructure to support the evolution of the industry,” said Charles Kaufmann, chief exec- utive – DHL Global Forwarding North Asia/South Pacific and pres- ident/ representative director – DHL Global Forwarding Japan. “Among the sector’s brightest growth spots are new frontier discoveries that demand extreme- ly-sensitive and intelligent logis- tics handling.” Recognising the potential of the industry, newly appointed country manager for DHL Global Forward- ing Australia George Lawson ex- pects its life sciences and health- care portfolio to be an important growth pillar for the business. “Technological advancements and the support of a fully-tracea- ble supply chain are making Aus- tralia’s pharmaceutical products more affordable and accessible to patients everywhere. “With our team of sector ex- perts, I am confident the growth of our life science and healthcare business will secure our mar- ket-leading position in Australia even as we tackle escalating vola- tility in global trade,” Lawson said.